Author Correction: Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial
For patients living with hypereosinophilic syndrome (HES), the body becomes a battlefield. This proves a rare and often unpredictable condition where the bone marrow overproduces eosinophils—white … Read more